Expression of cytokeratin 20 in the blood of patients with disseminated carcinoma of the pancreas, colon, stomach, and lung

Genady Chausovsky,Michael Luchansky,A. Figer,Jeremy Shapira,M. Gottfried,B. Novis,Galina Bogelman,R. Zemer,S. Zimlichman,A. Klein
DOI: https://doi.org/10.1002/(SICI)1097-0142(19991201)86:11<2398::AID-CNCR30>3.0.CO;2-5
IF: 6.9209
1999-12-01
Cancer
Abstract:Cytokeratins are constituents of the intermediate filaments of epithelial cells that are expressed in various combinations depending on the epithelial type and the degree of differentiation. The recently identified cytokeratin 20 (CK‐20) was found to be expressed in colonic, gastric, and pancreatic carcinoma tumor tissues. A low rate of incidence of expression of CK‐20 was found in tumor tissue from lung carcinoma but no expression was found in blood even with the sensitive reverse transcriptase‐polymerase chain reaction (RT‐PCR) method. The objective of the current study was to examine whether CK‐20 expression in the blood can be used as a biomarker for the detection of dissemination in patients with carcinoma of the colon, stomach, and pancreas.
What problem does this paper attempt to address?